SABS
#3404
SAB Biotherapeutics, Inc. - Common Stock
3.6 0 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.49%
Monthly Change
-7.69%
6 month change
-9.77%
Year Change
+28.57%
Previous Close
3.7 3
Open
3.6 0
Low
3.6 0
High
3.6 0
Volume
31
Financials
- Market Capitalization 275.27 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.6
Price to sales ratio
966.37
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3381 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.64 USD | +1.80% | +2.77% | +47.85% | -3.60% | 287.16 M USD | ||
| 3396 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 19.01 USD | +2.37% | +3.54% | -17.49% | +87.66% | 279.03 M USD | ||
| 3411 |  MGNX MacroGenics, Inc. - Common Stock | 4.29 USD | -4.67% | -8.53% | +3.37% | +186.00% | 272.69 M USD | ||
| 3414 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.06 USD | +5.10% | +0.98% | +23.35% | +14.44% | 271.99 M USD |
Frequently asked questions about SAB Biotherapeutics, Inc. - Common Stock
What is the SAB Biotherapeutics, Inc. - Common Stock stock price today?
The current price of SAB Biotherapeutics, Inc. - Common Stock (SABS) is 3.6. Over the past 24 hours, the stock has changed by -3.49%. Follow the SABS chart for real-time price dynamics.
What is the stock ticker of SAB Biotherapeutics, Inc. - Common Stock?
SAB Biotherapeutics, Inc. - Common Stock trades under the ticker SABS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SAB Biotherapeutics, Inc. - Common Stock stock going up?
SABS has changed by -6.74% over the last week, -7.69% over the last month, and +28.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was SAB Biotherapeutics, Inc. - Common Stock net income for the last quarter?
SAB Biotherapeutics, Inc. - Common Stock reported net income of -18.87 M for the last quarter. The previous quarter showed -16.86 M, which means net income changed by -11.91%.
How many employees does SAB Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, SAB Biotherapeutics, Inc. - Common Stock has 86 employees. Workforce size can provide additional context about the company's scale and operations.
What is SAB Biotherapeutics, Inc. - Common Stock EBITDA?
SAB Biotherapeutics, Inc. - Common Stock EBITDA is -19.21 M, and its EBITDA margin is -37.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SAB Biotherapeutics, Inc. - Common Stock stock?
You can buy SAB Biotherapeutics, Inc. - Common Stock (SABS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SAB Biotherapeutics, Inc. - Common Stock stock?
Investing in SAB Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SABS chart and related analysis on metatrader.com as part of your research.